Why BGPT?
logo

Assess an author's data and outputs

See the raw experimental evidence behind an author's publications and reproducibility signals.







Press Enter ↡ to solve



    Fuel Your Discoveries




     Quick Explanation


    Michelle Fodor appears to have strong, structure-driven expertise in allosteric regulation of SHP2/PTPN11, supported by multiple orthogonal structural/biophysical/cellular studies and a particularly detailed mechanistic structural study of the MRAS–SHOC2–PP1C holophosphatase complex (Nature, 2022).



     Long Explanation


    Author Review β€” Michelle Fodor
    Evidence scope: this review is constrained to (i) the author/works metadata you provided and (ii) the single paper’s raw, detailed study-extract you provided for Structure of the MRAS–SHOC2–PP1C phosphatase complex (Nature, 2022, DOI below). Where the dataset you provided does not include full experimental text for other papers, I do not claim mechanistic details for those other works.
    VISUAL 1 β€” Publication/impact signal over time (from your OpenAlex-like counts)
    Note: This plot uses only the numeric values you provided; no external bibliometric lookups were performed in this response.
    VISUAL 2 β€” Mechanistic evidence bundle (single deep-dive paper)
    For the one paper where you provided a rich experimental extract, I map evidence types to the key mechanistic claims (assembly/cooperativity, interface logic, functional consequence, and orthogonal validation).
    Deep scientific critique (raw-extract grounded): MRAS–SHOC2–PP1C structural mechanism
    Paper
    10.1038/s41586-022-05086-1 β€” Structure of the MRAS–SHOC2–PP1C phosphatase complex (Nature, 2022).
    What is known (from the provided extract)
    • Cooperative assembly logic: The ternary MRAS–SHOC2–PP1C complex formation is described as driven by GTP-bound MRAS, with SHOC2 acting as a bridge between MRAS and PP1CΞ±, producing selective RAF Ser259 dephosphorylation in vitro.
    • Structural anchoring: The study includes X-ray crystallography of apo SHOC2 and the ternary complex (PDB deposits referenced in your extract as 7TYG and 7TXH).
    • Mechanistic integration with mutations: Rasopathy/oncogenic mutation mapping is described as clustering at protein-protein interfaces and modifying holoenzyme formation/flux toward RAF activation.
    What is inferred vs uncertain (skeptical boundary)
    • Cellular context generalization: The extract itself flags limitations: in vitro reconstitution may not recapitulate full cellular context/membrane effects; and mechanistic generalization across all in vivo contexts is not fully proven.
    • MRAS preference vs isoform substitution: The extract says canonical RAS isoforms can substitute but with less cooperativity in certain contexts; however, exact determinants of preference across tissues/conditions are inherently difficult and remain a possible source of residual uncertainty.
    Critical evaluation of scientific strength
    Strengths in the evidence stack (based on your extract): the study combines orthogonal biophysics (SPR, SEC/AUC), atomic-resolution structural data (X-ray), computational dynamics (MD + clustering), and functional/cellular readouts (RAF dephosphorylation, MiaPaca2 genetic manipulations, and DepMap dependency analyses).
    Key red-flag to watch: the author-team includes substantial industry employment/shareholding. Your extract includes explicit COI statements (Novartis employees/shareholders; MF is a former Novartis employee). While structural mechanistic studies are often less prone to narrative-only β€œspin,” COI can still affect which hypotheses are prioritized and what uncertainties are emphasized. Importantly, your extract also states the mechanistic data are supported by multiple orthogonal methodsβ€”so the COI is a risk factor, not automatically evidence of wrongdoing.
    VISUAL 3 β€” Study workflow map (from the provided extract)
    This diagram is a faithful schematic of assay categories explicitly listed in your provided extract.
    Author-level pattern (what your provided worklist suggests, with strict epistemic limits)
    Your provided paper list for M. Fodor is heavily enriched for allosteric inhibition / structural biology around SHP2/PTPN11 (e.g., multiple structures of SHP2 with allosteric inhibitors and mechanistic inhibitor-identification/optimization manuscripts). However, because the prompt does not include full extracts for each of those works, I cannot responsibly attribute specific experimental rigor outcomes (e.g., crystallographic resolution, assay orthogonality, in vivo confirmation strength) to every item.
    What would most improve a next revision of this author review
    • Provide (or allow BGPT to fetch) full-text study extracts for 3–8 of the most-cited SHP2-related papers in your list, so the review can quantify reproducibility patterns (assay triangulation, blinding, independent replication, in vivo correlation strength).
    • Include the author’s publication-level contribution context (first/middle/last author) and any available method/reagent transparency details (data deposition completeness beyond structures; access to raw binding/kinetics data).
    • For the mechanistic theme (allostery), compile whether interface-resistance mutations produce consistent resistance phenotypes across multiple model systems.


    Feedback:    

    Updated: April 18, 2026

     BGPT Author Review


    Scientific Quality

    80%

    Based on the single provided deep experimental extract, the author’s work appears to sit in a rigorous structural/biophysical/mechanistic lane: it uses multiple orthogonal assay classes (biophysics, crystallography, dynamics, and functional/cellular validation) to support a mechanistic model. Main scientific uncertainty is that the broader author publication list was not provided with equivalent full experimental extracts, so I cannot evaluate consistency of rigor across the whole corpus; also the COI notes (industry employment/shareholding) create a bias risk that must be handled skeptically even if the data are multi-modal.


    Communication Quality

    70%

    From the provided material, communication quality is not directly verifiable (no direct writing samples). The structured extract you supplied reads as technically detailed and method-aware, suggesting competent scientific communication, but I cannot assess narrative clarity, quantitative presentation style, or how uncertainties are handled across the author’s other papers.


    Author Novelty

    70%

    The MRAS–SHOC2–PP1C structural mechanism indicates a concrete new assembly model for a central signaling node, consistent with novelty. However, without comparable extracts from the full works list, I cannot determine whether novelty is consistently high across the author’s broader output or is concentrated in a subset of papers.


    Scientific Rigor

    80%

    The provided extract describes a high-rigor experimental stack (purification, SPR, AUC/SEC, X-ray structures, MD simulations, competition/interaction assays, and cellular/dependency context). The main rigor gap is typical of mechanistic structural biology: in vitro reconstitution and context-dependent cellular translation always leave residual uncertainty, and the interpretive risk from industry COI must be accounted for.

     Analysis Wizard



    Would parse provided PDB accession metadata and extract interface residue lists to build a mutation-to-interface mapping table, then stratifies enrichment of rasopathy positions across the interface residues you provide.



     Hypothesis Graveyard


    A pure correlation model where MRAS co-localization alone explains dependency (without cooperative assembly) is weakened by the stated cooperativity-driven assembly and the in vitro functional selectivity described in the structural extract.


    That MRAS is universally required across all cell contexts is less consistent with the extract’s claim that canonical RAS isoforms can substitute (though with reduced cooperativity) in certain contexts, implying context-dependent preference rather than absolute requirement.

     Science Art


    Author Review: Michelle Fodor Science Art

     Science Movie


    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion








    Get Ahead With Science Insights

    Custom summaries of the latest cutting edge Science research. Every Friday. No Ads.


    My BGPT






     Trending